润达医疗股价涨5.07%，华西基金旗下1只基金重仓，持有17.28万股浮盈赚取15.72万元

Group 1 - The core point of the news is that RunDa Medical's stock price increased by 5.07% to 18.85 CNY per share, with a total market capitalization of 11.379 billion CNY [1] - RunDa Medical, established on January 6, 1999, specializes in providing in vitro diagnostic products and professional technical support to various medical laboratories through its comprehensive service system [1] - The company's main revenue sources are: reagents and other consumables (93.50%), instruments (3.70%), software development and services (2.67%), and others (0.14%) [1] Group 2 - Huaxi Fund has a significant holding in RunDa Medical, with the Huaxi Research Selected Mixed Fund A (020444) holding 172,800 shares, representing 5.28% of the fund's net value, making it the seventh-largest holding [2] - The fund has generated a floating profit of approximately 157,200 CNY today, with a total fund size of 51.9921 million CNY [2] - Year-to-date, the fund has achieved a return of 10.02%, ranking 555 out of 9012 in its category, and a one-year return of 16.66%, ranking 5721 out of 8157 [2]